INTERVIEWS

Dr. W. Michael Korn, Chief Medical Officer at Caris Life Sciences®, discusses the data presentation from the American Society of Clinical Oncology, (ASCO20) Virtual Scientific Program, Abstract 4629/Poster 237: Enrichment of alterations in targetable molecular pathways are enriched in KRAS wild-type (WT) pancreatic cancer (PC).

Dr. Chadi Nabhan, Chairman of Precision Oncology Alliance™ at Caris Life Sciences® and Dr. Stephen Liu, an oncologist with Medstar Health and an investigator on this study discuss the data presentation from the American Society of Clinical Oncology, (ASCO20) Virtual Scientific Program, Abstract 9544/Poster 310: Characterization of KRAS mutations in non-small cell lung cancer (NSCLC).

Returning guest, Dr. Jacqueline A. Nicholas, MD, MPH, discusses multiple sclerosis (MS) and MS relapses.  She talks about the recently FDA approved ZEPOSIA® (ozanimod) a new oral therapy to treat appropriate adult patients with relapsing forms of MS and other complications.

Dr. Rollie Carlson, CEO of Immunexpress discusses the development and commercialization plans for SeptiCyte® RAPID.  SeptiCyte® RAPID is a test that quantifies the immune response to infection and will provide actionable results in about one hour to guide physicians when making patient management decisions.

Dr. Craig Rayner, president of Certara’s Integrated Drug Development and Strategic Consulting Services discusses the COVID-19 Pharmacology Online Resource Center funded by the Bill & Melinda Gates Foundation and the programs they are working on to accelerate the treatment for COVID-19.

Justin Williams, founder and CEO of Noteworth, a healthcare delivery platform, discusses the biggest issues facing telehealth today, particularly in rural areas, how revenue is suffering but telehealth is bringing over 70 percent of practices online and in contact with patients, avoiding staff cuts.  He and his team have launched a specific platform to solely monitor and screen COVID-19 and is currently tracking over 2,000 COVID patients.

June 12, 2020, is International NASH Day and Wayne Eskridge, cirrhosis patient and founder of the Fatty Liver Foundation and Donna Cryer, liver transplant patient and the president and CEO of the Global Liver Institute discuss non-alcoholic steatohepatitis (NASH) and concerns surrounding NASH during COVID-19.

Physician, professor, and Medical Futurist, Dr. Dan O’Brien, discusses CRISPR technology and its application in detecting COVID-19 and how it’s the key to re-opening society.

Dr. Aaron Katz, MD, Chairman of Urology at NYU Winthrop Hospital and Professor of Urology NYU School of Medicine, discusses the Oncotype DX Genomic Prostate Score® (GPS™) test and how it is used by physicians and he covers the Abstract from the American Urological Association (AUA) 2020 meeting titled “A 17 -Gene RT RT-PCR Prostate Assay: Clinical Experience in 33,000 Patients with Clinically Low-Risk Prostate Cancer” 

Returning guest, rheumatologist and gout expert, Dr. N. Lawrence Edwards discusses the new 2020 American College of Rheumatology (ACR) Guideline for the Management of Gout.  Dr. Edwards is also the chairman of the Gout Education Society, a nonprofit organization dedicated to raising awareness of gout and providing free educational materials to medical professionals and patients or caregivers.